Posted by admin on Jun 15th, 2022

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating) reached a new 52-week low on Wednesday . The stock traded as low as $34.83 and last traded at $35.88, with a volume of 177877 shares trading hands. The stock had previously closed at $35.59.

Several brokerages have issued reports on XRAY. TheStreet cut shares of DENTSPLY SIRONA from a “b-” rating to a “c+” rating in a report on Friday, March 18th. UBS Group raised shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating and reduced their price objective for the stock from $58.00 to $47.00 in a research note on Wednesday, June 1st. HC Wainwright cut their price target on DENTSPLY SIRONA from $58.00 to $48.00 and set a “hold” rating on the stock in a report on Friday, April 22nd. Barrington Research decreased their price objective on DENTSPLY SIRONA from $53.00 to $51.00 in a research note on Wednesday, May 11th. Finally, The Goldman Sachs Group cut their target price on DENTSPLY SIRONA from $59.00 to $47.00 and set a “neutral” rating on the stock in a research note on Thursday, April 21st. Six investment analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $50.56.

The stock has a 50 day moving average of $41.12 and a 200-day moving average of $48.72. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.03 and a current ratio of 1.45. The company has a market cap of $7.67 billion, a PE ratio of 21.06 and a beta of 0.94.

DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) last announced its quarterly earnings data on Tuesday, May 10th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.02. DENTSPLY SIRONA had a return on equity of 11.63% and a net margin of 8.81%. The firm had revenue of $9.67 billion during the quarter, compared to analysts’ expectations of $982.05 million. During the same period last year, the business posted $0.72 earnings per share. The company’s revenue for the quarter was up 841.1% compared to the same quarter last year. Equities research analysts forecast that DENTSPLY SIRONA Inc. will post 2.42 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 8th. Investors of record on Friday, June 24th will be issued a dividend of $0.125 per share. The ex-dividend date of this dividend is Thursday, June 23rd. This represents a $0.50 annualized dividend and a dividend yield of 1.40%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently 29.59%.

In other DENTSPLY SIRONA news, Director Eric Brandt sold 6,900 shares of DENTSPLY SIRONA stock in a transaction dated Tuesday, May 3rd. The stock was sold at an average price of $39.71, for a total transaction of $273,999.00. Following the completion of the transaction, the director now owns 35,155 shares in the company, valued at approximately $1,396,005.05. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.76% of the stock is currently owned by corporate insiders.

Institutional investors and hedge funds have recently bought and sold shares of the stock. First Trust Advisors LP increased its holdings in DENTSPLY SIRONA by 203.9% in the first quarter. First Trust Advisors LP now owns 91,083 shares of the medical instruments supplier’s stock valued at $4,517,000 after buying an additional 61,111 shares in the last quarter. Amundi Pioneer Asset Management Inc. raised its holdings in DENTSPLY SIRONA by 39.9% in the 1st quarter. Amundi Pioneer Asset Management Inc. now owns 184,628 shares of the medical instruments supplier’s stock worth $9,157,000 after purchasing an additional 52,645 shares during the period. Morgan Stanley boosted its position in DENTSPLY SIRONA by 16.1% during the second quarter. Morgan Stanley now owns 607,754 shares of the medical instruments supplier’s stock worth $38,445,000 after purchasing an additional 84,088 shares in the last quarter. Franklin Resources Inc. grew its holdings in DENTSPLY SIRONA by 51.6% in the third quarter. Franklin Resources Inc. now owns 15,034 shares of the medical instruments supplier’s stock valued at $873,000 after purchasing an additional 5,118 shares during the period. Finally, Dark Forest Capital Management LP purchased a new stake in shares of DENTSPLY SIRONA in the third quarter valued at approximately $50,000. Hedge funds and other institutional investors own 94.79% of the company’s stock.

About DENTSPLY SIRONA (NASDAQ:XRAY)

DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces.

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

Diamcor Mining (CVE:DMI) Sets New 1-Year Low at $0.20

Radian Group (NYSE:RDN) Sets New 1-Year Low at $19.05